| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 03/13/1997 | WO1997009043A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | CA2231114A1 Two-photon upconverting dyes and applications |
| 03/12/1997 | EP0760679A1 Photodynamic conjugates with biocidal properties |
| 03/12/1997 | EP0468997B1 Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 03/11/1997 | US5610175 9-Substituted porphycenes |
| 03/04/1997 | US5608053 Absorbers of electromagnetic radiation |
| 03/04/1997 | US5607924 DNA photocleavage using texaphyrins |
| 03/01/1997 | WO1997007734A1 Microporation of human skin for drug delivery and monitoring applications |
| 02/27/1997 | WO1997007101A1 Radiation-activated cytotoxin therapy |
| 02/27/1997 | WO1997006846A1 Process for increasing the electromagnetic compatibility of field-generating equipment with biological systems by field attenuation, process for determining and transmitting information on electromagnetic fields, and data carrier used therefor |
| 02/27/1997 | WO1997006797A1 Endometrial ablation using photodynamic therapy with green porphyrins |
| 02/27/1997 | CA2229662A1 Endometrial ablation using photodynamic therapy with green porphyrins |
| 02/27/1997 | CA2229460A1 Radiation-activated cytotoxin therapy |
| 02/25/1997 | US5606045 Oligonucleotide linked to detectably labeled marker component which comprises porphyrin fluorophore moiety linked to two solubilizing polyoxyhydrocarbyl moieties |
| 02/20/1997 | WO1997005904A2 Use of metal clusters as a contrast or radiotherapy agent |
| 02/20/1997 | WO1997000638A3 Apparatus and method for making gas-filled vesicles of optimal size |
| 02/20/1997 | DE19529967A1 Verfahren zur Erhöhung der elektromagnetischen Verträglichkeit felderzeugender Geräte gegenüber biologischen Systemen durch Feldreduzierung, Verfahren zur Ermittlung und Übertragung von Feldinformationen aus elektromagnetischen Feldern, sowie hierbei verwendeter Datenträger A method for increasing the electromagnetic compatibility field generating device to biological systems by field reduction, methods to identify and transfer of field information from electromagnetic fields, and this volume being used |
| 02/19/1997 | EP0758331A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
| 02/19/1997 | EP0758250A1 Texaphyrin solid-supports and devices |
| 02/18/1997 | US5603962 Administering an antitumor agent obtained by actinic irradiation of an aqueous sulfuric acid solution |
| 02/18/1997 | US5603915 Process for manufacturing homeopathic medicines |
| 02/13/1997 | WO1997005155A1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use |
| 02/13/1997 | WO1997005127A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | WO1997004832A1 Enhanced transdermal transport using ultrasound |
| 02/13/1997 | WO1997004746A1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers |
| 02/13/1997 | WO1996040274A3 Chelating polymers as contrast agents for medical imaging |
| 02/13/1997 | CA2227808A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | CA2200984A1 Enhanced transdermal transfer using ultrasound |
| 02/12/1997 | EP0757690A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 02/12/1997 | EP0757689A1 Porphocyanine and cnc-expanded porphyrins |
| 02/11/1997 | US5602184 Monoterpenes, sesquiterpenes and diterpenes as cancer therapy |
| 02/11/1997 | US5601802 Administering a texaphyrin |
| 02/06/1997 | WO1997003706A1 Method and apparatus for inactivating contaminants in blood products |
| 02/06/1997 | WO1997003697A2 Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
| 02/06/1997 | WO1997003681A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene |
| 02/06/1997 | WO1996041144A3 Polyoxyhydrocarbyl marker products and methods for fluorescence assays |
| 02/06/1997 | CA2227370A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene |
| 02/06/1997 | CA2227212A1 Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
| 02/05/1997 | EP0756477A1 Methods for phototherapeutic treatment of proliferative skin diseases |
| 02/04/1997 | US5599928 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy |
| 02/04/1997 | US5599924 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 02/04/1997 | US5599923 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy |
| 02/04/1997 | US5599831 Converting amphipathic drug to lipophilic derivative capable of reconversion by lysosomal enzymes, combining with lipophilic carrier |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 01/30/1997 | DE19529025A1 Neue 8-bromsubstituierte cyclische Nucleotidester, Verfahren zu ihrer Herstellung und ihre Verwendung New 8-bromo-substituted cyclic Nucleotidester, processes for their preparation and their use |
| 01/23/1997 | WO1996040253A3 Rna photocleavage using texaphyrins |
| 01/23/1997 | WO1996025947A3 Induction of e-selectin for targetting therapeutic agents |
| 01/21/1997 | US5595726 Porphyrin type chromophore conjugated to oligonucleotide, fluorescence, detection of tumors, screening for hiv |
| 01/16/1997 | WO1997001355A1 Magnetic or electromagnetically induced energization of natural substances |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0723548A4 Phosphorescent compounds for imaging tissue oxygen |
| 01/15/1997 | CN1140410A Vitamin E and derivs. preventing damage in red cells sterilized by phthalocyanines and light |
| 01/14/1997 | US5594136 Useful in the separation of neutral and anionic species, phosphate ester hydrolysis, magnetic resonance imaging and photodynamic therapy |
| 01/14/1997 | US5593823 Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens |
| 01/09/1997 | WO1997000638A2 Apparatus and method for making gas-filled vesicles of optimal size |
| 01/07/1997 | US5591847 Diagnosis and treatment of cancer and tumors |
| 01/07/1997 | US5591422 Texaphyrin complexes having improved functionalization |
| 12/24/1996 | US5587490 Method of inactivation of viral and bacterial blood contaminants |
| 12/24/1996 | US5587478 Sapphyrin multimers |
| 12/24/1996 | US5587463 Texaphyrin macrocycles and metal complexes thereof |
| 12/24/1996 | US5587394 Production and use of diels alder adducts of vinyl porphyrins, of metal complexes thereof, and of compositions containing such adducts and complexes |
| 12/24/1996 | US5587371 Effective for treating hypoxic areas of solid neoplasms |
| 12/19/1996 | WO1996041144A2 Polyoxyhydrocarbyl marker products and methods for fluorescence assays |
| 12/19/1996 | WO1996040274A2 Chelating polymers as contrast agents for medical imaging |
| 12/19/1996 | WO1996040253A2 Rna photocleavage using texaphyrins |
| 12/19/1996 | WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 12/19/1996 | WO1996040108A1 Multidentate metal complexes and methods of making and using thereof |
| 12/19/1996 | WO1996040091A1 Dual functional cytotoxic/radiosensitizer compounds and methods for the preparation thereof |
| 12/19/1996 | WO1996039816A1 Method of inactivation of viral and bacterial blood contaminants |
| 12/19/1996 | WO1996039815A1 Psoralen-binding polymers |
| 12/19/1996 | WO1996031237A3 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 12/19/1996 | CA2224115A1 Multidentate metal complexes and methods of making and using thereof |
| 12/19/1996 | CA2223456A1 Chelating polymers as contrast agents for medical imaging |
| 12/19/1996 | CA2221733A1 Method of inactivation of viral and bacterial blood contaminants |
| 12/17/1996 | US5585503 Compounds for the photodecontamination of pathogens in blood |
| 12/17/1996 | US5585112 Method of preparing gas and gaseous precursor-filled microspheres |
| 12/12/1996 | WO1996039531A1 Delivery of nucleotides into organisms by electroporation |
| 12/12/1996 | WO1996039188A1 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 12/12/1996 | WO1996039079A1 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
| 12/12/1996 | CA2220756A1 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
| 12/10/1996 | US5583242 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation |
| 12/10/1996 | US5583220 Pyrole nitrogen-substituted texaphyrins |
| 12/05/1996 | WO1996038461A1 Cleavage of rna using metal complexes |
| 12/05/1996 | DE19520942A1 Medication prodn. |
| 12/05/1996 | CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex |
| 12/04/1996 | EP0745085A1 Texaphyrin metal complexes having improved functionalization |
| 12/04/1996 | EP0621785B1 Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells |
| 12/03/1996 | US5580575 Therapeutic drug delivery systems |
| 12/03/1996 | US5580543 Texaphyrins as radiation sensitizers |
| 11/26/1996 | US5578736 Substituted psoralens |
| 11/26/1996 | CA1338737C Porphyrins and cancer treatment |
| 11/21/1996 | WO1996036704A1 Methods of use of phthalocyanines to inactivate blood borne parasites |
| 11/21/1996 | WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 11/21/1996 | DE19514515A1 Magnetisable iron oxide nano-particle dispersion with high saturation polarisation |
| 11/21/1996 | CA2221716A1 Methods of use of phthalocyanines to inactivate blood borne parasites |
| 11/21/1996 | CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 11/20/1996 | EP0743015A1 Health tea and method of producing same |
| 11/20/1996 | EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| 11/19/1996 | US5576013 Treating vascular and neoplastic tissues |
| 11/14/1996 | WO1996032134A3 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |